Historically, no attempt is made to check for cancer unless there are symptoms.
Now a new breakthrough may change the Cancer Landscape.
Researchers at MGH’s Center for Systems Biology have developed a hand-held nanotechnology device that can assess in as little as 2 hours , with a drop of blood, cancer generated microvesicles. ( Microvesicles are slightly larger than proteins but smaller than cancer cells).
In the past these microvesicles have been ignored. The number and type of microvesicles can help determine cancer type and presence.
More work needs to be done, but there is a good chance that your doctors office may have this device in 3-5 years. Checking for cancer may just become part of the normal blood test.
There are over 250 kinds of cancer known at this time. Many of these can not be detected until it is too late.
Evaluating treatment has been delayed or slow. Changing chemotherapy choices and radiation targets more timely will lead to much higher success rates.